Renacarb Injection 10 mg/ml contains Carboplatin, a chemotherapy medication belonging to the platinum-based antineoplastic agents. It is primarily used to treat various types of cancer, including ovarian, lung, head and neck, and bladder cancers. Carboplatin works by interfering with the DNA replication process in cancer cells, preventing their growth and division, ultimately leading to cell death.

Compared to its predecessor, cisplatin, Carboplatin is generally associated with reduced kidney toxicity and fewer gastrointestinal side effects, making it a widely used alternative in oncology. Renacarb Injection is administered intravenously under strict medical supervision in a hospital or oncology clinic, ensuring precise dosing and monitoring for side effects.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

Each ml of Renacarb Injection contains:

• Carboplatin – 10 mg

Mechanism of Action

Carboplatin is a bifunctional alkylating agent that forms covalent bonds with DNA. Its anticancer activity involves the following steps:

• DNA cross-linking: Carboplatin binds to DNA strands, forming intra-strand and inter-strand cross-links.

• Disruption of replication: The cross-links prevent DNA replication and transcription.

• Induction of apoptosis: Cancer cells are unable to repair the DNA damage, leading to programmed cell death.

By selectively targeting rapidly dividing cancer cells, Carboplatin helps reduce tumor growth and progression.

Indications

Renacarb Injection 10 mg/ml is indicated for the treatment of:

• Ovarian cancer

• Non-small cell and small cell lung cancer

• Head and neck cancers

• Bladder cancer

• Other solid tumors as determined by an oncologist

It is often used in combination with other chemotherapy agents to enhance therapeutic effectiveness.

Dosage and Administration

The dosage of Renacarb Injection is individualized based on the patient’s body surface area, kidney function, and type of cancer.

• Route: Intravenous infusion

• Frequency: Typically administered every 3–4 weeks, depending on the chemotherapy regimen

• Monitoring: Blood counts, kidney function, and liver function should be closely monitored before and during treatment

The injection should only be administered by trained healthcare professionals experienced in chemotherapy administration. Proper hydration and premedication may be recommended to reduce the risk of side effects.

Possible Side Effects

Common side effects may include:

• Nausea and vomiting

• Decreased blood cell counts (anemia, neutropenia, thrombocytopenia)

• Fatigue

• Loss of appetite

• Hair thinning or hair loss

Serious but less frequent side effects may include:

• Severe allergic reactions

• Kidney toxicity

• Neuropathy (numbness or tingling in hands and feet)

• Electrolyte imbalances

Patients should report any unusual or severe symptoms to their healthcare provider immediately.

Precautions and Warnings

Before receiving Renacarb Injection, patients should inform their doctor if they have:

• Kidney or liver impairment

• Blood disorders

• Allergies to platinum compounds

• Pregnancy or breastfeeding

Carboplatin can cause fetal harm, so effective contraception is required during and after treatment.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage

• Store below 25°C

• Protect from light

• Use immediately after dilution, following hospital protocols

Conclusion

Renacarb Injection 10 mg/ml (Carboplatin) is a platinum-based chemotherapy agent used to treat various solid tumors. By interfering with DNA replication, it effectively reduces tumor growth. Proper administration under medical supervision and monitoring of side effects are essential for safe and effective cancer therapy.